当前位置:首页 - 行情中心 - 汉森制药(002412) - 财务分析 - 现金流量表

汉森制药

(002412)

  

流通市值:33.60亿  总市值:33.97亿
流通股本:4.98亿   总股本:5.03亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金546,253,645.98255,364,690.85966,151,105.91768,385,720.4
  收到的税费返还0---
  收到其他与经营活动有关的现金4,491,075.751,372,259.2621,693,877.9332,584,594.13
  经营活动现金流入小计550,744,721.73256,736,950.11987,844,983.84800,970,314.53
  购买商品、接受劳务支付的现金73,024,350.1737,387,993.76123,159,449.01167,020,077.76
  支付给职工以及为职工支付的现金115,545,609.7367,477,182.22192,045,271.31146,270,287.76
  支付的各项税费103,710,305.1342,457,086.08192,732,614.77134,160,734.14
  支付其他与经营活动有关的现金148,362,698.4260,007,606.3349,123,852.76214,530,696.65
  经营活动现金流出小计440,642,963.45207,329,868.36857,061,187.85661,981,796.31
  经营活动产生的现金流量净额110,101,758.2849,407,081.75130,783,795.99138,988,518.22
二、投资活动产生的现金流量:
  收回投资收到的现金806,000,000296,500,0001,002,733,752.42740,500,000
  取得投资收益收到的现金2,199,250.141,465,601.1616,231,339.931,259,219.37
  处置固定资产、无形资产和其他长期资产收回的现金净额1,775.66-2,927.449,919.12
  处置子公司及其他营业单位收到的现金净额0---
  收到的其他与投资活动有关的现金247,500-1,477,210.31,484,175
  投资活动现金流入小计808,448,525.8297,965,601.161,020,445,230.09743,253,313.49
  购建固定资产、无形资产和其他长期资产支付的现金8,688,480.214,846,011.211,635,432.296,487,009.32
  投资支付的现金875,200,000381,900,0001,041,000,000851,000,000
  质押贷款净增加额0---
  取得子公司及其他营业单位支付的现金0---
  支付其他与投资活动有关的现金0-10,000,000-
  投资活动现金流出小计883,888,480.21386,746,011.21,062,635,432.29857,487,009.32
  投资活动产生的现金流量净额-75,439,954.41-88,780,410.04-42,190,202.2-114,233,695.83
三、筹资活动产生的现金流量:
  吸收投资收到的现金0---
  其中:子公司吸收少数股东投资收到的现金0---
  取得借款收到的现金50,000,000-84,379,17670,000,000
  收到其他与筹资活动有关的现金0--8,212,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计50,000,000-84,379,17678,212,000
  偿还债务支付的现金68,000,000-95,000,00090,000,000
  分配股利、利润或偿付利息支付的现金1,093,458.32360,4752,551,336.232,019,501.53
  其中:子公司支付给少数股东的股利、利润0---
  支付其他与筹资活动有关的现金0--177,846.26
  筹资活动现金流出小计69,093,458.32360,47597,551,336.2392,197,347.79
  筹资活动产生的现金流量净额-19,093,458.32-360,475-13,172,160.23-13,985,347.79
五、现金及现金等价物净增加额15,568,345.55-39,733,803.2975,421,433.5610,769,474.6
  加:期初现金及现金等价物余额126,548,637.4126,548,637.451,127,203.8451,127,203.84
  期末现金及现金等价物余额142,116,982.9586,814,834.11126,548,637.461,896,678.44
补充资料:
  净利润68,538,438.13-220,244,409.11-
  资产减值准备-3,834.07-126,720.18-
  固定资产和投资性房地产折旧19,075,283.82-39,300,218.07-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,075,283.82-39,300,218.07-
  无形资产摊销777,330.52-1,463,462.92-
  长期待摊费用摊销371,525.55-718,684.08-
  处置固定资产、无形资产和其他长期资产的损失448,853.73---
  固定资产报废损失121.46-165,988.47-
  公允价值变动损失-898,900.83--2,073,590.91-
  财务费用899,865.74-2,007,566.8-
  投资损失39,497,582.73--9,972,397.05-
  递延所得税-2,787.34--153,531.68-
  其中:递延所得税资产减少127,032.62-72,757.71-
    递延所得税负债增加-129,819.96--226,289.39-
  存货的减少15,895,670.75-8,183,802.5-
  经营性应收项目的减少-18,504,622.58--110,318,546.04-
  经营性应付项目的增加-17,569,196.53--18,549,899.25-
  其他-1,092,414.58---
  现金的期末余额142,116,982.95-126,548,637.4-
  减:现金的期初余额126,548,637.4-51,127,203.84-
  现金及现金等价物的净增加额15,568,345.55-75,421,433.56-
公告日期2025-08-262025-04-262025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑